Nuveen Asset Management, LLC Medicinova Inc Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.76 - $5.14 $693,622 - $948,196	-184,474 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.81 - $8.74 $21,952 - $39,889	-4,564 Reduced 2.41%	184,474 $931,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $6.31 $38,238 - $47,968	-7,602 Reduced 3.87%	189,038 $995,000
Q3 2020 Nov 16, 2020	BUY	$4.67 - $11.0 $58,902 - $138,743	12,613 Added 6.85%	196,640 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $7.06 $131,586 - $303,594	43,002 Added 30.49%	184,027 $998,000
Q1 2020 May 14, 2020	SELL	$2.9 - $6.97 $104 - $250	-36 Reduced 0.03%	141,025 $524,000
Q3 2019 Nov 14, 2019	SELL	$7.7 - $10.42 $66,066 - $89,403	-8,580 Reduced 5.73%	141,061 $1.12 Million
Q2 2019 Aug 15, 2019	BUY	$8.29 - $13.22 $1.24 Million - $1.98 Million	149,641 New	149,641 $1.44 Million

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $104M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.